Abstract Adipose tissue engineering for breast reconstruction can be performed for patients who have undergone breast surgery. We have previously confirmed adipogenesis in mice implanted with type I collagen sponge with controlled release of fibroblast growth factor 2 (FGF2) and human adipose tissue-derived stem cells. However, in order to use this approach to treat breast cancer patients, a large amount of adipose tissue is needed, and FGF2 is not readily available. Thus, we aimed to regenerate large amounts of adipose tissue without FGF2 for a long period. Under general anesthesia, cages made of polypropylene mesh were implanted into the rabbits' bilateral fat pads. Each cage was 10 mm in radius and 10 mm in height. Minced type I collagen sponge was injected as a scaffold into the cage. Regenerated tissue in the cage was examined with ultrasonography, and the cages were harvested 3, 6, and 12 months after the implantation. Ultrasonography revealed a gradually increasing homogeneous high-echo area in the cage. Histology of the specimen was assessed with hematoxylin and eosin staining. The percentages of regenerated adipose tissue area were 76.2 ± 13.0 and 92.8 ± 6.6 % at 6 and 12 months after the implantation, respectively. Our results showed de novo adipogenesis 12 months after the implantation of only type I collagen sponge inside the space. Ultrasonography is a noninvasive and useful method of assessing the growth of the tissue inside the cage. This simple method could be a promising clinical modality in breast reconstruction.
Introduction
Breast cancer is a common disease among women worldwide. Breast surgery is available as a local treatment for breast cancer, although it is not the best treatment since any defect of the breast is distressing for patients. There are many breast reconstruction techniques, but each has its drawbacks. For example, silicone implants can induce a foreign body response and may present an obstacle during breast cancer screening. Autologous tissue graft implantation is a long surgical procedure that results in operation scars at many sites. Autologous fat transfer has the drawbacks of shrinkage, fat necrosis, or oil cyst formation [1] . On the other hand, adipose tissue engineering for breast reconstruction is a viable alternative for patients who have undergone breast surgery.
A previous study confirmed the occurrence of adipogenesis in mice implanted with a type I collagen sponge with controlled release of fibroblast growth factor 2 (FGF2) and human adipose tissue-derived stem cells (ASCs) [2] . We showed that human ASCs function not only as progenitor cells for in vivo adipogenesis, but also induce de novo adipogenesis in a type I collagen scaffold. ASCs are adipose tissue-specific progenitor cells, and differentiate into adipocytes or vascular cells. Type I collagen exists widely in the animal body and exhibits good biocompatibility, gelatification, and structural stability. Hence, type I collagen is a superior material for use in regenerative medicine [3] [4] [5] . FGF2 enhances adipogenesis [6, 7] , but FGF2 is not readily available for breast cancer patients. Furthermore, a large amount of adipose tissue is needed for a long period. In addition, some diagnostic modalities are needed when following up the implant. One aim of the study described in the present paper was to regenerate large amounts of adipose tissue without FGF2 and to maintain it for a long period. Another aim of the study was to evaluate the usefulness of ultrasonography (USG) as a diagnostic modality.
Materials and methods

Materials
Polypropylene (PP) mesh was purchased from FLON Industry Inc. (Tokyo, Japan). We prepared a column cage made of PP mesh with a pore size of 200 lm and 5-0 prolene strings (Ethicon Inc., New Brunswick, NJ, USA). The radius of the cage was 10 mm, and its height was 10 mm. PELNAC, which is approved for artificial dermis, consisting of an atelocollagen sponge layer and a silicone layer, was kindly supplied by Gunze Co. Ltd. (Kyoto, Japan). The sheet was 82 9 60 mm in size. First, the silicone layer of PELNAC was removed. Next, 160 mg of the type I collagen layer were minced, and this was suspended in 8 mL of natural saline (Otsuka Pharmaceuticals Co. Ltd, Tokushima, Japan) in a 10 mL syringe.
Animal experiments
All of the animal experiments were reviewed by the Committee on the Ethics of Animal Experiments (Faculty of Medicine, Kyoto University, Kyoto, Japan) and performed in accordance with the Guidelines for Animal Experiments of the Faculty of Medicine, Kyoto University.
Female New Zealand white rabbits (2.5-3.0 kg; Shimizu Laboratory Supply, Kyoto, Japan) were used. General anesthesia was applied through intramuscular injection of midazolam (4 mg/kg), medetomidine hydrochloride (0.16 mg/kg), and butorphanol tartrate (0.4 mg/kg). A PP cage was implanted into the New Zealand white rabbits' bilateral fat pads, and approximately 3.14 mL of the suspended type I collagen sponge were injected into the cage with a 16G intravenous cannula. Finally, the skin was closed with a buried suture. The implant was harvested 3, 6, and 12 months after implantation, and every specimen was assessed with hematoxylin-eosin (H-E) stain. Every experimental group consisted of four specimens. The percentage of regenerated adipose tissue area within a cage was calculated with NIH Image J software.
Ultrasonographic observation
Hitachi MyLab25 (Hitachi Medical Corporation, Tokyo, Japan) was used, and USG was performed under general anesthesia at 1 week and at 1, 3, 6, and 12 months after implantation.
Statistical analysis
Statistical differences were determined with a Wilcoxon test. Statistical significance was assigned when *P \ 0.05. JMP version 9 software (SAS Institute Inc., Cary, NC, USA) was used for statistical analysis.
Results
Ultrasonographic findings
The ultrasonographic findings are shown in Fig. 2 . An anechoic area and internal hyperechoic mass were noted inside the cage at one week (Fig. 1a) and one month after implantation (Fig. 1b) . A homogeneous high-echo area was detected inside the cage after the third month through to the twelfth month (Fig. 1c-e) .
Cross-section observation Figure 1f and g show the gross sections at three and sixmonths after implantation. At three months after implantation, the appearance of the inner side of the cage showed high water content (Fig. 1f) . At six months after the implantation, the appearance of the inner side of the cage became whitish compared to that of the specimen at three months (Fig. 1g ).
H-E staining Figure 1 shows the H-E staining of the specimen. At three months after implantation, type I collagen scaffold was observed mainly inside the cage under low magnification (Fig. 1I) . Under high magnification, several vacuoles were found, mainly at the margins of the cage (Fig. 1l) . These vacuoles were morphologically adipocytes. Further, many nuclei were seen within the scaffold. At six months, adipose tissue occupied a large part of the surface of the cross-section under low magnification (Fig. 1j) . Under high magnification, a large number of mature adipocytes were observed and angiogenesis was noted (Fig. 1m) . At 12 months, mature adipose tissue was observed, mostly inside the cage (Fig. 1k) . Complete (Fig. 1n) .
Percentage of regenerated adipose tissue area
Average percentages of regenerated adipose tissue area within a cage were 31.7 ± 10.3, 76.2 ± 13.0, and 92.8 ± 6.6 % at 3, 6, and 12 months after implantation, respectively (Fig. 2) . Regenerated adipose tissue areas at 6 and 12 months were significantly increased compared to that at 3 months after implantation (P = 0.03).
Discussion
Tissue engineering requires a cell source, a scaffold, and growth factors [8] . In line with these requirements, we previously confirmed the occurrence of adipogenesis in mice by implanting ASCs with a type I collagen scaffold with controlled release of FGF2 [2] . Further, we confirmed that adipogenesis occurred in situ in rabbits by implanting type I collagen with the controlled release of FGF2. Repeated administration of the mixture of collagen scaffold and gelatin microspheres containing FGF2 led to significantly greater area at three months after implantation than achieved with a single administration of each component [9] . In this study, implanting type I collagen inside the cage without ASCs and controlled release of FGF2 resulted in adipogenesis. The average percentage of regenerated adipose tissue within the cage was 92.8 ± 6.6 % at 12 months after implantation. A type I collagen sponge implanted into the PP cage recruited an adequate cell source and necessary growth factors. FGF2 is a potent angiogenic factor that is known to be effective for adipogenesis [6, 7] . However, FGF2 cannot be used clinically to treat malignant diseases, because FGF2 is a potent obreast carcinogen [10] . Our method, which involves adipose tissue engineering without FGF2, is a promising way to use FGF2 for clinical purposes.
Some mechanisms of adipogenesis have been reported. First, type I collagen sponge is known to be a superior scaffold for ASC adhesion because of its porous structure [5, 7] . Generally, cells cannot survive in the absence of adhesive materials. So, the observation in this study that lots of nuclei with recruited cells were observed in the scaffold three months after implantation suggested that these cells were precursors of mature adipocytes and adhered to a type I collagen sponge. Collagen degradation is essential for cell migration, proliferation, and differentiation. Type I collagen scaffold degraded and mature adipose tissue was generated inside the cage six months after implantation. Mature adipose tissue still remained 12 months after implantation. O'Connor et al. [11] reported a higher rate of adipogenic differentiation in vitro with type I collagen than with fibronectin. We have confirmed that type I collagen is an excellent scaffold for adipogenesis in vivo. Secondly, the fat pad was an excellent implantation site for adipogenesis. Because the fat tissue in this study was healthy, the optimal conditions for adipogenesis were satisfied. ASCs are present in the adipose tissue and are derived from the surrounding tissue. For example, administration of a cell source or growth factors might be required for efficient adipogenesis when the fat tissue has received radiation therapy. Third, the growth factors required for adipogenesis were produced after implantation. Several growth factors were produced at the operation site after surgery. Soluble FGF2, vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), epidermal growth factor, or insulin-like growth factor-1 (IGF-1) were detected in the wound drainage fluid [12] . FGF2 and PDGF promote ASC proliferation in vitro [13] . FGF2 and VEGF are potent angiogenic factors. Angiogenesis facilitates blood supply and oxygen flow to the scaffolds. Blood vessel formation was confirmed after six months of implantation in this study. Adipose tissue engineering requires in vivo vascularization, and in vivo vascularization enhanced the formation of engineered adipose tissue. Growth factors were produced after the surgery and contributed to adipogenesis.
The reconstruction of volume-stable adipose tissue for a long period is a great challenge. Although the subcutaneous environment is relatively static, the skin exerts a compressive force on any material placed subcutaneously. It might also be necessary to maintain some extra spaces in order to accommodate the volume-stable adipose tissue [14] . In this study, PP mesh was used to maintain this space and is a marker of the engineered adipose tissue area. Although it is easy to detect PP mesh with USG, this material is nonabsorbable and too hard for breast reconstruction. Further studies will be needed to identify soft and absorbable Fig. 2 Percentages of regenerated adipose tissue area within a cage at 3, 6 and 12 months after implantation. Data are mean ± standard deviation from n = 4; asterisks indicate statistical differences at P \ 0.05 materials that can be used to maintain extra space so that this technique can be applied in clinical situations.
It is important to evaluate the regenerated adipose tissue. We used USG to follow up the implant over time. Regenerated tissue can be distinguished from areas with water content or empty spaces. USG is usually used for breast examination, because it is easy to perform, noninvasive, does not involve radiation exposure, and is cost-effective as compared to computed tomography, mammography, or magnetic resonance imaging. Thus, USG is a useful modality to assess engineered adipose tissue.
Conclusion
We achieved complete regeneration of adipose tissue inside the cage at 12 months after implantation only by implanting a type I collagen sponge inside the space. When monitored using USG, an anechoic area and an internal hyperechoic mass gradually disappeared and were replaced with a homogeneous high-echo area, reflecting adipogenesis. USG is a noninvasive and useful method to examine the contents inside the cage.
